<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">3 Biotech</journal-id><journal-id journal-id-type="iso-abbrev">3 Biotech</journal-id><journal-title-group><journal-title>3 Biotech</journal-title></journal-title-group><issn pub-type="ppub">2190-572X</issn><issn pub-type="epub">2190-5738</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28324411</article-id><article-id pub-id-type="pmc">4624138</article-id><article-id pub-id-type="publisher-id">303</article-id><article-id pub-id-type="doi">10.1007/s13205-015-0303-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Screening and structure-based modeling of T-cell epitopes of Nipah virus proteome: an immunoinformatic approach for designing peptide-based vaccine</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kamthania</surname><given-names>Mohit</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Sharma</surname><given-names>D. K.</given-names></name><address><email>sharmadr_dinesh@yahoo.in</email></address><xref ref-type="aff" rid="Aff3"/></contrib><aff id="Aff1"><label/>Mangalayatan University, Aligarh-Mathura Highway, Beswan, Aligarh, Uttar Pradesh India </aff><aff id="Aff2"><label/>Jiwaji University, Gwalior, Madhya Pradesh India </aff><aff id="Aff3"><label/>Department of Zoology, Government Post Graduate College, Guna, Madhya Pradesh India </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>12</month><year>2015</year></pub-date><volume>5</volume><issue>6</issue><fpage>877</fpage><lpage>882</lpage><history><date date-type="received"><day>18</day><month>12</month><year>2014</year></date><date date-type="accepted"><day>15</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2015</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p>Identification of Nipah virus (NiV) T-cell-specific antigen is urgently needed for appropriate diagnostic and vaccination. In the present study, prediction and modeling of T-cell epitopes of Nipah virus antigenic proteins nucleocapsid, phosphoprotein, matrix, fusion, glycoprotein, L protein, W protein, V protein and C protein followed by the binding simulation studies of predicted highest binding scorers with their corresponding MHC class I alleles were done. Immunoinformatic tool ProPred1 was used to predict the promiscuous MHC class I epitopes of viral antigenic proteins. The molecular modelings of the epitopes were done by PEPstr server. And alleles structure were predicted by MODELLER 9.10. Molecular dynamics (MD) simulation studies were performed through the NAMD graphical user interface embedded in visual molecular dynamics. Epitopes VPATNSPEL, NPTAVPFTL and LLFVFGPNL of Nucleocapsid, V protein and Fusion protein have considerable binding energy and score with HLA-B7, HLA-B*2705 and HLA-A2MHC class I allele, respectively. These three predicted peptides are highly potential to induce T-cell-mediated immune response and are expected to be useful in designing epitope-based vaccines against Nipah virus after further testing by wet laboratory studies.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Nipah virus</kwd><kwd>Molecular modeling</kwd><kwd>T-cell epitope</kwd><kwd>Vaccine designing</kwd><kwd>MHC class I alleles</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; King Abdulaziz City for Science and Technology 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Nipah virus (NiV) was isolated in 1999 and was identified as the etiological agent responsible for an outbreak of severe respiratory disease and fatal encephalitis in Malaysia and Singapore in pigs and humans (Chua et al. <xref ref-type="bibr" rid="CR2">1999</xref>). During the first NiV outbreak, the virus infected both pigs and humans, in addition to a small number of cats, dogs and horses (Chua et al. <xref ref-type="bibr" rid="CR3">2000</xref>; Epstein et al. <xref ref-type="bibr" rid="CR4">2006</xref>). NiV, a member of the family Paramyxoviridae, possesses a negative-sense, non-segmented RNA genome that is 18,246 nt (Malaysian isolate) or 18,252 nt (Bangladesh isolate) in length (Harcourt et al. <xref ref-type="bibr" rid="CR7">2005</xref>). It has six transcription units that encode six structural proteins, the nucleocapsid (N), phosphoprotein (P), matrix protein (M), fusion protein (F), glycoprotein (G) and polymerase (L). Similar to other paramyxoviruses, the P gene of NiV expresses four proteins, namely P, V, W and C (Harcourt et al. <xref ref-type="bibr" rid="CR6">2000</xref>; Wang et al. <xref ref-type="bibr" rid="CR27">2001</xref>).</p><p>In Bangladesh, 135 probable or confirmed cases of NiV infection in humans were identified from 2001 through 2008; 98 (73&#x000a0;%) were fatal (Luby et al. <xref ref-type="bibr" rid="CR14">2009</xref>). Active Nipah virus encephalitis surveillance identified an encephalitis cluster and sporadic cases in Faridpur, Bangladesh, in January 2010. 16 case patients were identified, in which 14 of these patients died (Sazzad et al. <xref ref-type="bibr" rid="CR19">2013</xref>).</p><p>Vaccination is the most effective of all the medical interventions to save human and animal lives and to increase production (Horzinek <xref ref-type="bibr" rid="CR8">1999</xref>; Tang et al. <xref ref-type="bibr" rid="CR22">2012a</xref>). Compared to the conventional vaccines, peptide- or epitope-based vaccines are easy to produce, more specific, cost effective, less time consuming and also safe (Kumar et al. <xref ref-type="bibr" rid="CR12">2013</xref>). It is well established that T cells play a critical role in inducing cellular immune response against foreign antigens but they recognize antigenic fragments only when they are associated with major histocompatibility complex (MHC) molecules exposed on surface of all vertebrate cells (Shekhar et al. <xref ref-type="bibr" rid="CR20">2012</xref>; Mohabatkar and Mohammadzadegan <xref ref-type="bibr" rid="CR15">2007</xref>). Immunoinformatics approach uses computational algorithms to predict potential vaccine candidates or T-cell epitopes. The advantage of a peptide- or epitope-based vaccine is the ability to deliver high doses of the potential immunogen and at a low cost (Von Hoff et al. <xref ref-type="bibr" rid="CR25">2005</xref>; Tang et al. <xref ref-type="bibr" rid="CR23">2012b</xref>). Viral protein which could act as a vaccine candidate must be surface-exposed, antigenic and responsible for pathogenicity (Cerdino-Tarraga et al. <xref ref-type="bibr" rid="CR1">2003</xref>; Verma et al. <xref ref-type="bibr" rid="CR24">2011</xref>).</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><p>The amino acid sequence of Nucleocapsid, phosphoprotein, matrix, fusion, glycoprotein, L protein, W protein, V protein and C protein was retrieved from the protein sequence database of NCBI (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein">http://www.ncbi.nlm.nih.gov/protein</ext-link>) and their accession number is shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Scores generated by ProPred for MHC class I</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Protein</th><th align="left">Accession no.</th><th align="left">Length of amino acid</th><th align="left">Start position</th><th align="left">Peptides/epitope</th><th align="left">Allele</th><th align="left">ProPred score</th></tr></thead><tbody><tr><td align="left" rowspan="2">Nucleocapsid</td><td align="left" rowspan="2">ACT32611</td><td align="left" rowspan="2">532</td><td align="left">38</td><td align="left">VPATNSPEL</td><td align="left">HLA-B7</td><td align="left">1200</td></tr><tr><td align="left">474</td><td align="left">SLLNLRSRL</td><td align="left">HLA-A2</td><td align="left">5968.882</td></tr><tr><td align="left" rowspan="2">Phosphoprotein</td><td align="left" rowspan="2">ACT32612</td><td align="left" rowspan="2">709</td><td align="left">624</td><td align="left">EPYGAAVQL</td><td align="left">HLA-B*5102</td><td align="left">2640</td></tr><tr><td align="left">464</td><td align="left">NPADDNDSL</td><td align="left">HLA-B*5102</td><td align="left">550</td></tr><tr><td align="left" rowspan="2">Matrix</td><td align="left" rowspan="2">ACT32613</td><td align="left" rowspan="2">352</td><td align="left">201</td><td align="left">IAFNLLVYL</td><td align="left">HLA-A*0201</td><td align="left">4702.218</td></tr><tr><td align="left">293</td><td align="left">FQKNLCFSL</td><td align="left">HLA-B*2705</td><td align="left">3000</td></tr><tr><td align="left" rowspan="3">Fusion</td><td align="left" rowspan="3">ACT32614</td><td align="left" rowspan="3">546</td><td align="left">209</td><td align="left">LLFVFGPNL</td><td align="left">HLA-A2</td><td align="left">2678.131</td></tr><tr><td align="left">192</td><td align="left">KQTELSLDL</td><td align="left">HLA-B*2705</td><td align="left">9000</td></tr><tr><td align="left">125</td><td align="left">AQITAGVAL</td><td align="left">HLA-B*2705</td><td align="left">2000</td></tr><tr><td align="left" rowspan="3">Glycoprotein</td><td align="left" rowspan="3">ACT32615</td><td align="left" rowspan="3">602</td><td align="left">247</td><td align="left">RIIGVGEVL</td><td align="left">HLA-B*2705</td><td align="left">2000</td></tr><tr><td align="left">38</td><td align="left">EGLLDSKIL</td><td align="left">HLA-B*5102</td><td align="left">4400</td></tr><tr><td align="left">45</td><td align="left">ILSAFNTVI</td><td align="left">HLA-A2</td><td align="left">3901.211</td></tr><tr><td align="left" rowspan="2">L protein</td><td align="left" rowspan="2">ACT32616</td><td align="left" rowspan="2">2244</td><td align="left">1688</td><td align="left">NPQEKICVL</td><td align="left">HLA-B*5102</td><td align="left">2662</td></tr><tr><td align="left">1482</td><td align="left">FPLWSTEEL</td><td align="left">HLA-B*5102</td><td align="left">5280</td></tr><tr><td align="left">W protein</td><td align="left">YP_007188592</td><td align="left">449</td><td align="left">66</td><td align="left">DGDVERRNL</td><td align="left">HLA-B*5101</td><td align="left">520</td></tr><tr><td align="left" rowspan="3">V protein</td><td align="left" rowspan="3">NP_112023</td><td align="left" rowspan="3">456</td><td align="left">186</td><td align="left">NPTAVPFTL</td><td align="left">HLA-B*2705</td><td align="left">2000</td></tr><tr><td align="left">66</td><td align="left">DGDVERRNL</td><td align="left">HLA-B*5101</td><td align="left">520</td></tr><tr><td align="left">316</td><td align="left">KEEPPQKRL</td><td align="left">HLA-B*2705</td><td align="left">2000</td></tr><tr><td align="left" rowspan="2">C protein</td><td align="left" rowspan="2">NP_112024</td><td align="left" rowspan="2">166</td><td align="left">116</td><td align="left">PDMDLLQAL</td><td align="left">HLA-B*2705</td><td align="left">2000</td></tr><tr><td align="left">0</td><td align="left">MMASILLTL</td><td align="left">HLA-B*2705</td><td align="left">2000</td></tr></tbody></table></table-wrap></p><sec id="Sec3"><title>Prediction of MHC class I binding peptides</title><p>The prediction of promiscuous MHC class I binding peptides was done using a popular immunoinformatic tool ProPred I (Singh and Raghava <xref ref-type="bibr" rid="CR21">2001</xref>). It is an online web tool which uses matrix-based method that allows the prediction of MHC-binding sites in an antigenic sequence for MHC class I alleles. It also allows the prediction of the standard proteasome and immunoproteasome cleavage sites in an antigenic sequence. The simultaneous prediction of MHC binders and proteasome cleavage sites in an antigenic sequence leads to the identification of potential T-cell epitopes.</p></sec><sec id="Sec4"><title>Structure-based modeling of T-cell epitopes</title><p>The PEPstr (peptide tertiary structure prediction server) server (Kaur et al. <xref ref-type="bibr" rid="CR11">2007</xref>) predicts the tertiary structure of small peptides with sequence length varying between 7 and 25 residues. The prediction strategy is based on the realization that &#x003b2;-turn is an important and consistent feature of small peptides in addition to regular structures. Thus, the methods use both the regular secondary structure information predicted from PSIPRED and &#x003b2;-turns information predicted from BetaTurns. The side-chain angles are placed using standard backbone-dependent rotamer library. The structure is further refined with energy minimization and molecular dynamic simulations using Amber version 6.</p></sec><sec id="Sec5"><title>Modeling and validation of MHC I alleles</title><p>The IMGT/HLA database (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/ipd/imgt/hla/intro.html">http://www.ebi.ac.uk/ipd/imgt/hla/intro.html</ext-link>) (Robinson et al. <xref ref-type="bibr" rid="CR17">2013</xref>) currently contains 10,103 allele sequences. In addition to the physical sequences, the database contains detailed information concerning the material from which the sequence was derived and data on the validation of the sequences. The IMGT/HLA database allows you to retrieve information upon a specific HLA allele (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/ipd/imgt/hla/allele.html">http://www.ebi.ac.uk/ipd/imgt/hla/allele.html</ext-link>) as named in the WHO Nomenclature Committee Reports. 3D structures of alleles were retrieved from IMGT/HLA database. Some of the allele&#x02019;s structures, which are not presented in IMGT/HLA database, were modeled with the help of MODELLER 9.10. The stereochemical qualities of the alleles were checked by PROCHECK (Laskowski et al. <xref ref-type="bibr" rid="CR13">1993</xref>).</p></sec><sec id="Sec6"><title>Molecular docking</title><p>Docking of peptides and alleles structure was carried out using AutoDock 4.2 (Goodsell and Olson <xref ref-type="bibr" rid="CR5">1990</xref>; Morris et al. <xref ref-type="bibr" rid="CR16">1998</xref>). Gasteiger charges were added to the ligand and maximum six numbers of active torsion are given to the lead compound using AutoDock tool (<ext-link ext-link-type="uri" xlink:href="http://autodock.scripps.edu/resources/adt">http://autodock.scripps.edu/resources/adt</ext-link>). Kollaman charges and solvation term were added to the protein structure using AutoDock tool. The Grid for docking calculation was centered to cover the protein-binding site residues and accommodate ligand to move freely. During the docking procedure, a Lamarckian genetic algorithm (LGA) was used for flexible ligand rigid protein docking calculation. Docking parameters were as follows: 30 docking trials, population size of 150, maximum number of energy evaluation ranges of 250,000, maximum number of generations is 27,000, mutation rate of 0.02, cross-over rate of 0.8, other docking parameters were set to the software&#x02019;s default values.</p></sec><sec id="Sec7"><title>Molecular dynamics simulation of epitope and HLA allele complex</title><p>Molecular dynamics simulation was done using the NAMD graphical interface module (James et al. <xref ref-type="bibr" rid="CR10">2005</xref>) incorporated visual molecular dynamics (VMD 1.9.2) (Humphrey et al. <xref ref-type="bibr" rid="CR9">1996</xref>). A protein structure file (psf) stores structural information of the protein, such as various types of bonding interactions. The psf was created from the initial pdb and topology files. The psfgen package of VMD is used to create this. To create a psf, we will first make a pgn file, which will be the target of psfgen. After running psfgen, two new files were generated protein pdb and protein psf and by accessing PSF and PDB files; NAMD generated the trajectory DCD file. Root mean square deviation (RMSD) of the complex was completed using rmsd tcl source file from the Tk console and finally rmsd dat was saved and accessed in Microsoft office excel 2007.</p></sec></sec><sec id="Sec8"><title>Results and discussion</title><sec id="Sec9"><title>Prediction and analysis of MHC class I binding peptides</title><p>The Nucleocapsid peptide VPATNSPEL at position 38&#x02013;46 showed ProPred score of 1200 with HLA-B7 MHCI allele. The V protein peptide NPTAVPFTL at position 186&#x02013;194 showed ProPred score of 2000 with the HLA-B*2705 allele. And the fusion protein peptide LLFVFGPNL at position 209&#x02013;217 showed ProPred score of 2678.131 with the HLA-A2 allele. ProPred scores of peptides with MHC I alleles are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.</p></sec><sec id="Sec10"><title>Docking energy determination by AutoDock</title><p>3-D coordinate files of allele were obtained through IMGT/HLA database or model through MODELLER (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>) were validated using PROCHECK tool. After that, binding simulation studies show that nucleocapsid epitope VPATNSPEL with HLA-B7 allele, V protein epitope NPTAVPFTL with HLA-B*2705 allele as well as fusion epitope LLFVFGPNL with HLA-A2 allele formed stable HLA&#x02013;peptide complexes with the energy minimization values of &#x02212;5.07, &#x02212;3.13 and &#x02212;3.11&#x000a0;kcal/mol, respectively (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). After docking studies, we determined the number of H bonds present in the stable complex formed.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>List of class I MHC alleles considered in this study for prediction of binding peptides</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">S. no.</th><th align="left">Allele</th><th align="left">Template (PDB ID)</th><th align="left">Crystal structure/model</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">HLA-B7</td><td align="left">3VCL</td><td align="left">Crystal structure</td></tr><tr><td align="left">2</td><td align="left">HLA-A2</td><td align="left">1AKJ</td><td align="left">Crystal structure</td></tr><tr><td align="left">3</td><td align="left">HLA-B*5102</td><td align="left">1E27</td><td align="left">Model</td></tr><tr><td align="left">4</td><td align="left">HLA-A*0201</td><td align="left">1AKJ</td><td align="left">Crystal structure</td></tr><tr><td align="left">5</td><td align="left">HLA-B*2705</td><td align="left">1HSA</td><td align="left">Crystal structure</td></tr><tr><td align="left">6</td><td align="left">HLA-B*5101</td><td align="left">1E27</td><td align="left">Crystal structure</td></tr></tbody></table><table-wrap-foot><p>The table lists the PDB IDs of the template used for prediction and whether it was a crystal structure or a structural model</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Docking result of epitopes with allele structures</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Protein</th><th align="left">Peptide/epitope</th><th align="left">Allele</th><th align="left">BE</th><th align="left">IME</th><th align="left">IE</th><th align="left">TorE</th><th align="left">VdwE</th><th align="left">EE</th></tr></thead><tbody><tr><td align="left" rowspan="2">Nucleocapsid</td><td align="left">VPATNSPEL</td><td align="left">HLA-B7</td><td char="." align="char">&#x02212;5.07</td><td char="." align="char">&#x02212;12.52</td><td char="." align="char">&#x02212;4.06</td><td char="." align="char">7.46</td><td char="." align="char">&#x02212;9.47</td><td char="." align="char">&#x02212;3.05</td></tr><tr><td align="left">SLLNLRSRL</td><td align="left">HLA-A2</td><td char="." align="char">&#x02212;1.45</td><td char="." align="char">&#x02212;12.49</td><td char="." align="char">&#x02212;4.94</td><td char="." align="char">11.04</td><td char="." align="char">&#x02212;11.75</td><td char="." align="char">&#x02212;0.74</td></tr><tr><td align="left" rowspan="2">Phosphoprotein</td><td align="left">EPYGAAVQL</td><td align="left">HLA-B*5102</td><td char="." align="char">&#x02212;1.27</td><td char="." align="char">&#x02212;9.33</td><td char="." align="char">&#x02212;7.82</td><td char="." align="char">8.05</td><td char="." align="char">&#x02212;9.57</td><td char="." align="char">0.24</td></tr><tr><td align="left">NPADDNDSL</td><td align="left">HLA-B*5102</td><td char="." align="char">&#x02212;0.65</td><td char="." align="char">&#x02212;9.3</td><td char="." align="char">&#x02212;0.89</td><td char="." align="char">8.65</td><td char="." align="char">&#x02212;8.13</td><td char="." align="char">&#x02212;1.16</td></tr><tr><td align="left" rowspan="2">Matrix</td><td align="left">IAFNLLVYL</td><td align="left">HLA-A*0201</td><td char="." align="char">&#x02212;1.98</td><td char="." align="char">&#x02212;11.52</td><td char="." align="char">&#x02212;5.23</td><td char="." align="char">9.55</td><td char="." align="char">&#x02212;11.3</td><td char="." align="char">&#x02212;0.22</td></tr><tr><td align="left">FQKNLCFSL</td><td align="left">HLA-B*2705</td><td char="." align="char">0.35</td><td char="." align="char">&#x02212;10.39</td><td char="." align="char">&#x02212;4.94</td><td char="." align="char">10.74</td><td char="." align="char">&#x02212;8.36</td><td char="." align="char">&#x02212;2.03</td></tr><tr><td align="left" rowspan="3">Fusion</td><td align="left">LLFVFGPNL</td><td align="left">HLA-A2</td><td char="." align="char">&#x02212;3.11</td><td char="." align="char">&#x02212;11.76</td><td char="." align="char">&#x02212;4.98</td><td char="." align="char">8.65</td><td char="." align="char">&#x02212;10.47</td><td char="." align="char">&#x02212;1.29</td></tr><tr><td align="left">KQTELSLDL</td><td align="left">HLA-B*2705</td><td char="." align="char">2.72</td><td char="." align="char">&#x02212;8.32</td><td char="." align="char">&#x02212;6.03</td><td char="." align="char">11.04</td><td char="." align="char">&#x02212;8.14</td><td char="." align="char">&#x02212;0.18</td></tr><tr><td align="left">AQITAGVAL</td><td align="left">HLA-B*2705</td><td char="." align="char">&#x02212;0.64</td><td char="." align="char">&#x02212;8.39</td><td char="." align="char">&#x02212;3.49</td><td char="." align="char">7.76</td><td char="." align="char">&#x02212;6.6</td><td char="." align="char">&#x02212;1.8</td></tr><tr><td align="left" rowspan="3">Glycoprotein</td><td align="left">RIIGVGEVL</td><td align="left">HLA-B*2705</td><td char="." align="char">0.36</td><td char="." align="char">&#x02212;9.18</td><td char="." align="char">&#x02212;3.76</td><td char="." align="char">9.55</td><td char="." align="char">&#x02212;8.49</td><td char="." align="char">&#x02212;0.69</td></tr><tr><td align="left">EGLLDSKIL</td><td align="left">HLA-B*5102</td><td char="." align="char">0.05</td><td char="." align="char">&#x02212;10.39</td><td char="." align="char">&#x02212;5.75</td><td char="." align="char">10.44</td><td char="." align="char">&#x02212;10.13</td><td char="." align="char">&#x02212;0.26</td></tr><tr><td align="left">ILSAFNTVI</td><td align="left">HLA-A2</td><td char="." align="char">&#x02212;1.04</td><td char="." align="char">&#x02212;9.98</td><td char="." align="char">&#x02212;8.09</td><td char="." align="char">8.95</td><td char="." align="char">&#x02212;9.94</td><td char="." align="char">&#x02212;0.05</td></tr><tr><td align="left" rowspan="2">L protein</td><td align="left">NPQEKICVL</td><td align="left">HLA-B*5102</td><td char="." align="char">0.55</td><td char="." align="char">&#x02212;10.49</td><td char="." align="char">&#x02212;5.44</td><td char="." align="char">11.04</td><td char="." align="char">&#x02212;10.62</td><td char="." align="char">0.14</td></tr><tr><td align="left">FPLWSTEEL</td><td align="left">HLA-B*5102</td><td char="." align="char">1.31</td><td char="." align="char">&#x02212;8.53</td><td char="." align="char">&#x02212;6.14</td><td char="." align="char">9.84</td><td char="." align="char">&#x02212;7.25</td><td char="." align="char">&#x02212;1.28</td></tr><tr><td align="left">W protein</td><td align="left">DGDVERRNL</td><td align="left">HLA-B*5101</td><td char="." align="char">2.58</td><td char="." align="char">&#x02212;8.46</td><td char="." align="char">&#x02212;3.91</td><td char="." align="char">11.04</td><td char="." align="char">&#x02212;8.34</td><td char="." align="char">&#x02212;0.12</td></tr><tr><td align="left" rowspan="3">V protein</td><td align="left">NPTAVPFTL</td><td align="left">HLA-B*2705</td><td char="." align="char">&#x02212;3.13</td><td char="." align="char">&#x02212;10.29</td><td char="." align="char">&#x02212;3.5</td><td char="." align="char">7.16</td><td char="." align="char">&#x02212;9.31</td><td char="." align="char">&#x02212;0.98</td></tr><tr><td align="left">DGDVERRNL</td><td align="left">HLA-B*5101</td><td char="." align="char">2.38</td><td char="." align="char">&#x02212;8.66</td><td char="." align="char">&#x02212;3.8</td><td char="." align="char">11.04</td><td char="." align="char">&#x02212;7.75</td><td char="." align="char">&#x02212;0.9</td></tr><tr><td align="left">KEEPPQKRL</td><td align="left">HLA-B*2705</td><td char="." align="char">&#x02212;0.26</td><td char="." align="char">&#x02212;11.59</td><td char="." align="char">&#x02212;4.3</td><td char="." align="char">11.34</td><td char="." align="char">&#x02212;8.63</td><td char="." align="char">&#x02212;2.97</td></tr><tr><td align="left" rowspan="2">C protein</td><td align="left">PDMDLLQAL</td><td align="left">HLA-B*2705</td><td char="." align="char">1.76</td><td char="." align="char">&#x02212;8.09</td><td char="." align="char">&#x02212;4.61</td><td char="." align="char">9.84</td><td char="." align="char">&#x02212;6.07</td><td char="." align="char">&#x02212;2.02</td></tr><tr><td align="left">MMASILLTL</td><td align="left">HLA-B*2705</td><td char="." align="char">&#x02212;2.38</td><td char="." align="char">&#x02212;12.22</td><td char="." align="char">&#x02212;2.54</td><td char="." align="char">9.84</td><td char="." align="char">&#x02212;11.46</td><td char="." align="char">&#x02212;0.76</td></tr></tbody></table><table-wrap-foot><p>
<italic>BE</italic> binding energy, <italic>IME</italic> intermolecular energy, <italic>IE</italic> internal energy, <italic>TorE</italic> torsional energy, <italic>VdwE</italic> Vdw-lbDesolv energy, <italic>EE</italic> electrostatic energy</p></table-wrap-foot></table-wrap></p><p>Using AutoDock, it was found that three H-bonds were present in peptide VPATNSPEL-HLA-B7 allele complex as shown in (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>), first H-bond formed between allele residue ASP30:O with epitope amino acid THR4:OG1, second H-bond formed between allele residue ARG48:NH2 with epitope amino acid GLU8:OE1 and third H-bond formed between allele residue TYR27:OH with epitope amino acid ALA3:O, whereas one H-bond was present in V protein peptide NPTAVPFTL - HLA-B*2705 allele complex (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) via residue ASP29:O with epitope amino acid ASN1:HN1. Fusion protein peptide LLFVFGPNL - HLA-A2 allele complex depicting position of amino acids along with formation of one H-bond with allele residue ASP122ASP122:OD2 with epitope amino acid LEU1:N (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Docked nucleocapsid protein peptide VPATNSPEL-HLA-B7 allele complex depicting position of amino acids along with the formation of 3 H bonds with ASP30, TYR27 and ARG48</p></caption><graphic xlink:href="13205_2015_303_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Docked V protein peptide NPTAVPFTL&#x02013;HLA-B*2705 allele complex depicting position of amino acids along with the formation of 1 H bond with ASP29</p></caption><graphic xlink:href="13205_2015_303_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Docked fusion protein peptide LLFVFGPNL&#x02013;HLA-A2 allele complex depicting position of amino acids along with the formation of 1 H bond with ASP122</p></caption><graphic xlink:href="13205_2015_303_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec11"><title>Molecular dynamics simulation of peptide&#x02013;allele complex through NAMD</title><p>The peptide&#x02013;allele complexes formed by AutoDock were subjected to molecular dynamics simulation and RMSD. Nucleocapsid epitope VPATNSPEL-HLA-B7 allele complex displayed the highest peak at RMSD value of 1.16 &#x000c5; (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). V protein peptide NPTAVPFTL-HLA-B*2705 allele complex resulted in highest peak at RMSD value of 0.46 &#x000c5; (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). And epitope LLFVFGPNL-HLA-A2 allele complex resulted in highest peak at RMSD value of 0.47 &#x000c5; (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>).<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Graph displaying molecular dynamic simulation of Nucleocapsid peptide&#x02013;allele complex, resulted in highest peak at 1.16 &#x000c5;</p></caption><graphic xlink:href="13205_2015_303_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Graph displaying molecular dynamic simulation of V protein peptide&#x02013;allele complex, resulted in highest peak at 0.46 &#x000c5;</p></caption><graphic xlink:href="13205_2015_303_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig.&#x000a0;6</label><caption><p>Graph displaying molecular dynamic simulation of fusion protein peptide&#x02013;allele complex, resulted in highest peak at 0.47 &#x000c5;</p></caption><graphic xlink:href="13205_2015_303_Fig6_HTML" id="MO6"/></fig></p><p>Nipah virus (NiV) was associated with highly lethal febrile encephalitis in humans and a predominantly respiratory disease in pigs. Periodic deadly outbreaks, documentation of person-to-person transmission, and the potential of this virus as an agent of agroterror reinforce the need for effective means of therapy and prevention (Walpita et al. <xref ref-type="bibr" rid="CR26">2011</xref>). The current study incorporates immunoinformatics approach for reducing the time consumed in the long array of experiments to avoid hit and trial sets. Walpita et al. (<xref ref-type="bibr" rid="CR26">2011</xref>) describe the vaccine potential of NiV proteins glycoprotein, fusion and matrix. Sakib et al. (<xref ref-type="bibr" rid="CR18">2014</xref>) designed epitope-based peptides for the utility of vaccine development by targeting glycoprotein G and envelope protein F of Nipah virus (NiV) that, respectively, facilitates attachment and fusion of NiV with host cells. AutoDock resulted in good binding affinity along with H bonds at default parameters. The molecular dynamics simulation showed that complex formed between a peptide and allele was attaining proper stability by creating a parallelism in RMSD over a time window. The mentioned peptides can be either isolated or formulated for further in vitro and in vivo testings.</p></sec></sec><sec id="Sec12" sec-type="conclusion"><title>Conclusion</title><p>The conclusion drawn from the present study is that the three epitopes VPATNSPEL, NPTAVPFTL and LLFVFGPNL of nucleocapsid, V protein and fusion protein, respectively, have considerable binding with HLA-B7, HLA-B*2705 and HLA-A2MHC class I allele and low-energy minimization values providing stability to the peptide&#x02013;MHC complex. These peptide constructs may further be undergone wet laboratory studies for the development of targeted vaccine against Nipah virus.</p></sec></body><back><ack><p>This study was conducted in the Department of Zoology, Government Post Graduate College, Guna, Madhya Pradesh, India. The author gratefully acknowledges the necessary computational facilities and constant supervision provided by the Dr. D.K. Sharma.</p><sec id="d30e1567"><title>Conflict of interest</title><p>The authors have no conflict of interest regarding the publication of this paper.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerdino-Tarraga</surname><given-names>AM</given-names></name><name><surname>Efstratiou</surname><given-names>A</given-names></name><name><surname>Dover</surname><given-names>LG</given-names></name><name><surname>Holden</surname><given-names>MTG</given-names></name><name><surname>Pallen</surname><given-names>M</given-names></name><etal/></person-group><article-title>The complete genome sequence and analysis of <italic>Corynebacterium diphtheria</italic> NCTC13129</article-title><source>Nucl Acids Res</source><year>2003</year><volume>31</volume><fpage>6516</fpage><lpage>6523</lpage><pub-id pub-id-type="doi">10.1093/nar/gkg874</pub-id><pub-id pub-id-type="pmid">14602910</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chua</surname><given-names>KB</given-names></name><name><surname>Goh</surname><given-names>KJ</given-names></name><name><surname>Wong</surname><given-names>KT</given-names></name><name><surname>Kamarulzaman</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>PS</given-names></name><name><surname>Ksiazek</surname><given-names>TG</given-names></name><name><surname>Zaki</surname><given-names>SR</given-names></name><name><surname>Paul</surname><given-names>G</given-names></name><name><surname>Lam</surname><given-names>SK</given-names></name><name><surname>Tan</surname><given-names>CT</given-names></name></person-group><article-title>Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia</article-title><source>Lancet</source><year>1999</year><volume>354</volume><fpage>1257</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(99)04299-3</pub-id><pub-id pub-id-type="pmid">10520635</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chua</surname><given-names>KB</given-names></name><name><surname>Bellini</surname><given-names>WJ</given-names></name><name><surname>Rota</surname><given-names>PA</given-names></name><name><surname>Harcourt</surname><given-names>BH</given-names></name><name><surname>Tamin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Nipah virus: a recently emergent deadly paramyxovirus</article-title><source>Science</source><year>2000</year><volume>288</volume><fpage>1432</fpage><lpage>1435</lpage><pub-id pub-id-type="doi">10.1126/science.288.5470.1432</pub-id><pub-id pub-id-type="pmid">10827955</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>JH</given-names></name><name><surname>Abdul Rahman</surname><given-names>S</given-names></name><name><surname>Zambriski</surname><given-names>JA</given-names></name><name><surname>Halpin</surname><given-names>K</given-names></name><name><surname>Meehan</surname><given-names>G</given-names></name><etal/></person-group><article-title>Feral cats and risk for Nipah virus transmission</article-title><source>Emerg Infect Dis</source><year>2006</year><volume>12</volume><fpage>1178</fpage><lpage>1179</lpage><pub-id pub-id-type="doi">10.3201/eid1207.050799</pub-id><pub-id pub-id-type="pmid">16848051</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodsell</surname><given-names>DS</given-names></name><name><surname>Olson</surname><given-names>AJ</given-names></name></person-group><article-title>Automated docking of substrates to proteins by simulated annealing</article-title><source>Proteins</source><year>1990</year><volume>8</volume><issue>3</issue><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1002/prot.340080302</pub-id><pub-id pub-id-type="pmid">2281083</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harcourt</surname><given-names>BH</given-names></name><name><surname>Tamin</surname><given-names>A</given-names></name><name><surname>Ksiazek</surname><given-names>TG</given-names></name><name><surname>Rollin</surname><given-names>PE</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Molecular characterization of Nipah virus, a newly emergent paramyxovirus</article-title><source>Virology</source><year>2000</year><volume>271</volume><fpage>334</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1006/viro.2000.0340</pub-id><pub-id pub-id-type="pmid">10860887</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harcourt</surname><given-names>BH</given-names></name><name><surname>Lowe</surname><given-names>L</given-names></name><name><surname>Tamin</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Bankamp</surname><given-names>B</given-names></name><etal/></person-group><article-title>Genetic characterization of Nipah virus, Bangladesh, 2004</article-title><source>Emerg Infect Dis</source><year>2005</year><volume>11</volume><fpage>1594</fpage><lpage>1597</lpage><pub-id pub-id-type="doi">10.3201/eid1110.050513</pub-id><pub-id pub-id-type="pmid">16318702</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horzinek</surname><given-names>MC</given-names></name></person-group><article-title>Vaccination: a philosophical view</article-title><source>Adv Vet Med</source><year>1999</year><volume>41</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/S0065-3519(99)80004-4</pub-id><pub-id pub-id-type="pmid">9890005</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphrey</surname><given-names>W</given-names></name><name><surname>Dalke</surname><given-names>A</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name></person-group><article-title>VMD-visual molecular dynamics</article-title><source>J Mol Gr</source><year>1996</year><volume>14</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/0263-7855(96)00018-5</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>CP</given-names></name><name><surname>Braun</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gumbart</surname><given-names>J</given-names></name><name><surname>Tajkhorshid</surname><given-names>E</given-names></name><name><surname>Villa</surname><given-names>E</given-names></name><name><surname>Chipot</surname><given-names>C</given-names></name><name><surname>Skeel</surname><given-names>RD</given-names></name><name><surname>Kale</surname><given-names>L</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name></person-group><article-title>Scalable molecular dynamics with NAMD</article-title><source>J Comput Chem</source><year>2005</year><volume>26</volume><fpage>1781</fpage><lpage>1802</lpage><pub-id pub-id-type="doi">10.1002/jcc.20289</pub-id><pub-id pub-id-type="pmid">16222654</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>H</given-names></name><name><surname>Garg</surname><given-names>A</given-names></name><name><surname>Raghava</surname><given-names>GPS</given-names></name></person-group><article-title>PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides</article-title><source>Protein PeptLett</source><year>2007</year><volume>14</volume><fpage>626</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.2174/092986607781483859</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Jain</surname><given-names>A</given-names></name><name><surname>Shraddha</surname><given-names>Verma SK</given-names></name></person-group><article-title>Screening and structure-based modeling of T-cell epitopes of Marburg virus NP, GP and VP40: an immunoinformatic approach for designing peptide-based vaccine</article-title><source>Trends Bioinform</source><year>2013</year><volume>6</volume><fpage>10</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.3923/tb.2013.10.16</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskowski</surname><given-names>RA</given-names></name><name><surname>MacArthur</surname><given-names>MW</given-names></name><name><surname>Moss</surname><given-names>DS</given-names></name><name><surname>Thornton</surname><given-names>JM</given-names></name></person-group><article-title>PROCHECK&#x02014;a program to check the stereochemical quality of protein structures</article-title><source>J App Cryst</source><year>1993</year><volume>26</volume><fpage>283</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1107/S0021889892009944</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luby</surname><given-names>SP</given-names></name><name><surname>Gurley</surname><given-names>ES</given-names></name><name><surname>Hossain</surname><given-names>MJ</given-names></name></person-group><article-title>Transmission of human infection with Nipah virus</article-title><source>Clin Infect Dis</source><year>2009</year><volume>49</volume><fpage>1743</fpage><lpage>1748</lpage><pub-id pub-id-type="doi">10.1086/647951</pub-id><pub-id pub-id-type="pmid">19886791</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohabatkar</surname><given-names>H</given-names></name><name><surname>Mohammadzadegan</surname><given-names>R</given-names></name></person-group><article-title>Computational comparison of T-cell epitopes of gp120 of Iranian HIV-1 with different subtypes of the virus</article-title><source>Pak J Biol Sci</source><year>2007</year><volume>10</volume><fpage>4295</fpage><lpage>4298</lpage><pub-id pub-id-type="doi">10.3923/pjbs.2007.4295.4298</pub-id><pub-id pub-id-type="pmid">19086590</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>GM</given-names></name><name><surname>Goodsell</surname><given-names>DS</given-names></name><name><surname>Halliday</surname><given-names>RS</given-names></name><name><surname>Huey</surname><given-names>R</given-names></name><name><surname>Hart</surname><given-names>WE</given-names></name><name><surname>Belew</surname><given-names>RK</given-names></name><name><surname>Olson</surname><given-names>AJ</given-names></name></person-group><article-title>Automated Docking using a Lamarckian genetic algorithm and empirical binding free energy function</article-title><source>J Comput Chem</source><year>1998</year><volume>19</volume><fpage>1639</fpage><lpage>1662</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(19981115)19:14&#x0003c;1639::AID-JCC10&#x0003e;3.0.CO;2-B</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Halliwell</surname><given-names>JA</given-names></name><name><surname>McWilliam</surname><given-names>H</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name><name><surname>Marsh</surname><given-names>SGE</given-names></name></person-group><article-title>The IMGT/HLA Database</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>D1222</fpage><lpage>D1227</lpage><pub-id pub-id-type="doi">10.1093/nar/gks949</pub-id><pub-id pub-id-type="pmid">23080122</pub-id></element-citation></ref><ref id="CR18"><mixed-citation publication-type="other">Sakib MS, Md. Islam R, MahbubHasan AKM, NurunNabi AHM (2014) Prediction of epitope-based peptides for the utility of vaccine development from fusion and glycoprotein of Nipah virus using in silico approach. Adv Bioinform, Article ID 402492, p 17</mixed-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sazzad</surname><given-names>HMS</given-names></name><name><surname>Hossain</surname><given-names>MJ</given-names></name><name><surname>Gurley</surname><given-names>ES</given-names></name><name><surname>Ameen</surname><given-names>KMH</given-names></name><name><surname>Parveen</surname><given-names>S</given-names></name><name><surname>Islam</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Nipah virus infection outbreak with nosocomial and corpse-to-human transmission, Bangladesh</article-title><source>Emerg Infect Dis</source><year>2013</year><volume>19</volume><issue>2</issue><fpage>210</fpage><pub-id pub-id-type="doi">10.3201/eid1902.120971</pub-id><pub-id pub-id-type="pmid">23347678</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shekhar</surname><given-names>C</given-names></name><name><surname>Dev</surname><given-names>K</given-names></name><name><surname>Verma</surname><given-names>SK</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><article-title>In-silico: screening and modeling of CTL binding epitopes of crimeancongo hemorrhagic fever virus</article-title><source>Trends Bioinform</source><year>2012</year><volume>5</volume><fpage>14</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.3923/tb.2012.14.24</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Raghava</surname><given-names>GPS</given-names></name></person-group><article-title>ProPred: prediction of HLA-DR binding sites</article-title><source>Bioinformatics</source><year>2001</year><volume>17</volume><issue>12</issue><fpage>1236</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/17.12.1236</pub-id><pub-id pub-id-type="pmid">11751237</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name><name><surname>Fang</surname><given-names>YZ</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>ZW</given-names></name><etal/></person-group><article-title>The epitopes of foot and mouth disease</article-title><source>Asian J Anim Vet Adv</source><year>2012</year><volume>7</volume><fpage>1261</fpage><lpage>1265</lpage><pub-id pub-id-type="doi">10.3923/ajava.2012.1261.1265</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name><name><surname>Fang</surname><given-names>YZ</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>ZW</given-names></name><etal/></person-group><article-title>Advances in studies on vaccines of foot-and-mouth disease</article-title><source>Asian J Anim Vet Adv</source><year>2012</year><volume>7</volume><fpage>1245</fpage><lpage>1254</lpage><pub-id pub-id-type="doi">10.3923/ajava.2012.1245.1254</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>SK</given-names></name><name><surname>Yadav</surname><given-names>SSP</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><article-title>In silico T-cell antigenic determinants from proteome of H1N2 swine influenza A virus</article-title><source>Online J Bioinform</source><year>2011</year><volume>12</volume><fpage>371</fpage><lpage>378</lpage></element-citation></ref><ref id="CR25"><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Von Hoff</surname><given-names>DD</given-names></name><name><surname>Evans</surname><given-names>DB</given-names></name><name><surname>Hruban</surname><given-names>RH</given-names></name></person-group><source>Pancreatic cancer</source><year>2005</year><publisher-loc>Sudbury</publisher-loc><publisher-name>Jones and Bartlett</publisher-name></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walpita</surname><given-names>P</given-names></name><name><surname>Barr</surname><given-names>J</given-names></name><name><surname>Sherman</surname><given-names>M</given-names></name><name><surname>Basler</surname><given-names>CF</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Vaccine potential of Nipah virus-like particles</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>4</issue><fpage>e18437</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0018437</pub-id><pub-id pub-id-type="pmid">21494680</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Harcourt</surname><given-names>BH</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Tamin</surname><given-names>A</given-names></name><name><surname>Rota</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Molecular biology of Hendra and Nipah viruses</article-title><source>Microbes Infect</source><year>2001</year><volume>3</volume><fpage>279</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/S1286-4579(01)01381-8</pub-id><pub-id pub-id-type="pmid">11334745</pub-id></element-citation></ref></ref-list></back></article>